Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine-Reference-Cited by-同舟云学术

Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine

Published:2011-09-27 Issue:12 Volume:6 Page:2203-2213
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Alcaro Stefano,Alteri Claudia,Artese Anna,Ceccherini-Silberstein Francesca,Costa Giosuè,Ortuso Francesco,Bertoli Ada,Forbici Federica,Santoro Maria Mercedes,Parrotta Lucia,Flandre Philippe,Masquelier Bernard,Descamps Diane,Calvez Vincent,Marcelin Anne-Genevieve,Perno Carlo Federico,Sing Tobias,Svicher Valentina

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference73 articles.

1. Inhibitors of HIV- I reverse transcriptase

2. Antiviral drugs in current clinical use

3. Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1

4. Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring novel HIV‐1 reverse transcriptase inhibitors with drug‐resistant mutants: A double mutant surprise;Protein Science;2023-11-20

2. Meet the Regional Editor;Current Enzyme Inhibition;2022-03

3. Nationwide Study of Drug Resistance Mutations in HIV-1 Infected Individuals under Antiretroviral Therapy in Brazil;International Journal of Molecular Sciences;2021-05-18

4. Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)–infected patients;Antiviral Therapy;2021-05

5. Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola;PLOS ONE;2019-11-26